Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MSD France

Division of Merck & Co. Inc.
www.msd-france.com

Latest From MSD France

AstraZeneca/MSD’s Koselugo Among 14 New Hopefuls At EMA

New drugs from Eli Lilly, Pfizer, Janssen, GSK, Arvelle, BioCryst, Diurnal and Myovant are also among the latest products the European Medicines Agency is evaluating for potential pan-EU approval.

Europe Approvals

Keytruda Dropped From England’s Cancer Drugs Fund For Bladder Cancer

MSD said it was disappointed by the decision by the health technology assessment body, NICE, and that it was considering what further actions are available to ensure eligible patients with advanced bladder cancer continue to have access to its medicine.

United Kingdom Health Technology Assessment

England’s NICE Rejects Tecentriq In Triple-Negative Breast Cancer

NICE draft guidance says that Tecentriq in combination with chemotherapy is not cost effective in untreated advanced triple-negative breast cancer.

United Kingdom Health Technology Assessment

New Keytruda Combo Wins Funding In England For NSCLC

MSD’s Keytruda will be paid for through the Cancer Drugs Fund for use in combination with carboplatin and paclitaxel as a first-line treatment for metastatic squamous non-small-cell lung cancer.

United Kingdom Reimbursement
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Merck & Co. Inc.
  • Senior Management
  • Michel Vounatsos, Managing Dir.
  • Contact Info
  • MSD France
    Phone: (33)
    Paris,
    France
UsernamePublicRestriction

Register